Peanut Genotypes with Reduced Content of Immunogenic Proteins by Breeding, Biotechnology, and Management: Prospects and Challenges
Peanut allergies affect millions of people worldwide, often causing life-threatening reactions and necessitating strict avoidance. Recent advancements in oral immunotherapy, such as Palforzia™, and IgE-mediated treatments (e.g., Xolair), have improved care options; however, their high costs limit ac...
Saved in:
| Main Authors: | Tariq Alam, Sachin Rustgi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Plants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2223-7747/14/4/626 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Immunotherapy with Standardized Peanut Extract: A Game-Changer for Peanut Allergy
by: Edoardo Cavaglià, et al.
Published: (2025-04-01) -
Aptamer-Enhanced Surface Decontamination: A Novel Approach for Neutralizing Peanut Allergens and Preventing Cell-Degranulation
by: Mohamad Ammar Ayass, et al.
Published: (2025-04-01) -
The safety and efficacy of oral immunotherapy compared to epicutaneous immunotherapy in peanut allergen desensitisation amongst the paediatric cohort—a narrative review
by: Ehtesam A. Chowdhury, et al.
Published: (2025-05-01) -
Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study
by: Victoria Landry, et al.
Published: (2024-10-01) -
Peanut challenges prior to oral immunotherapy demonstrate high tolerance rates in selected patients
by: Candice N. Gard, MD, et al.
Published: (2025-05-01)